UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

___________________

FORM 10-Q

___________________

☒	QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

	For the quarterly period ended: March 31, 2025

or

☐	TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

	For the transition period from: _____________ to _____________

Commission File Number: 000-53571

Dogecoin Cash, Inc.

(Exact name of registrant as specified in its charter)

Nevada		20-1898270
(State or Other Jurisdiction		(I.R.S. Employer
of Incorporation)		Identification No.)

355 W. Mesquite Blvd. #C-70

Mesquite, Nevada 89027

(Address of Principal Executive Office) (Zip Code)

(702) 762-3123

(Registrant’s telephone number, including area code)

N/A

(Former name, former address, and former fiscal year, if changed since last report)

———————

Securities registered pursuant to Section 12(b) of the Act:

Title of each class	Trading Symbol	Name of each exchange on which registered.
None

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. ☒ Yes ☐ No

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). ☒ Yes ☐ No

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer or a smaller reporting company. See the definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer	☐	Accelerated filer	☐
Non-accelerated Filer	☐	Smaller reporting company	☒
Emerging growth company	☒

If an emerging growth company, indicate by checkmark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).

☐ Yes ☒ No

The number of shares of the issuer’s Common Stock outstanding as of March 31, 2025 is 143,903,923.

PART I—FINANCIAL INFORMATION

Item 1. Financial Statements.

Attached after signature page.

Item 1C. Cybersecurity

We recognize the critical importance of developing, implementing, and maintaining robust cybersecurity measures to safeguard our information systems and protect the confidentiality, integrity, and availability of our data. We currently have security measures in place to protect our clients, customers, employees,‌ and vendor information and prevent data loss and other security breaches. We only use third party software for accounting, billing and payroll that has robust compliance and is actively involved in continuous assessment of risks from cybersecurity threats, including prevention, mitigation, detection, and remediation of cybersecurity incidents.

Our CEO is responsible for overseeing our business operations and is responsible for day-to-day assessment and confers weekly with subsidiary webmaster to understand any risks from cybersecurity threats, including the prevention, mitigation, detection, and remediation of cybersecurity incidents.

As our core operations are virtual, it is routine to undertake activities to prevent, detect, and minimize the effects of cybersecurity incidents, maintain business continuity, contingency, and have recovery plans for use in the event of a cybersecurity incident by the administering of local and cloud based back up of files and emails. We currently do not carry a cyber liability insurance policy but are evaluating whether to acquire one to mitigate any financial impact of a cybersecurity breach.

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations.

Certain statements in this Report constitute “forward-looking statements.” Such forward-looking statements involve known and unknown risks, uncertainties, and other factors that may cause our actual results, performance, or achievements to be materially different from any future results, performance, or achievements expressed or implied by such forward-looking statements. Factors that might cause such a difference include, among others, uncertainties relating to general economic and business conditions; industry trends; changes in demand for our products and services; uncertainties relating to customer plans and commitments and the timing of orders received from customers; announcements or changes in our pricing policies or that of our competitors; unanticipated delays in the development, market acceptance or installation of our products and services; changes in government regulations; availability of management and other key personnel; availability, terms, and deployment of capital; relationships with third-party equipment suppliers; and worldwide political stability and economic growth. The words “believe,” “expect,” “anticipate,” “intend” and “plan” and similar expressions identify forward-looking statements. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date the statement was made.

Results of Operations

Three Months Ended March 31, 2025 compared with the Three Months Ended March 31, 2024

	Three Months Ended
	A			B			A-B
	March 31,			March 31,			Change			Change %
	2025			2024			Change			Change %
REVENUE	$	184,473		$	225,131		$	(40,658)			(18)	%
Cost of revenues		67,506			99,018			(31,513)			(32)	%
Cost of sales % of total sales		37	%		44	%		(7)	%		(17)	%
Gross profit		116,967			126,113			(9,146)			(7)	%
Gross profit % of sales		63	%		56	%
EXPENSES
Professional fees		37,860			57,637			(19,777)			(34)	%
Depreciation and amortization		301			2,425			(2,124)			(88)	%
Wages and salaries		73,390			114,071			(40,681)			(36)	%
Advertising		1,861			1,880			(19)			(1)	%
General and administrative		105,169			124,891			(19,722)			(16)	%
Total expenses		218,581			300,904			(82,323)			(27)	%
NET LOSS FOR THE PERIOD FROM CONTINUING OPERATIONS		(101,614)			(174,791)			73,177			(42)	%

Revenue for the three months ended March 31, 2025, decreased 18% compared to the three months ended March 31, 2024. Cost of revenues as a percentage of sales decreased 32% between the periods. The decrease in revenues is primarily a result of the significant increase in competition for market share in the cannabis tele-medicine industry. This decrease in the demand for our service continued during the first quarter of 2025.

Total operating expenses decreased in March 31, 2025 compared with 2024 which trended down as did revenue in the current period. Decreases in depreciation and amortization, wages and salaries and general and administrative expenses. PrestoDoctor management salaries also decreased in the three months ended March 31, 2025.

Liquidity and Capital Resources

Cash provided by operating activities was $4,129 in the three months ended March 31, 2025. We ended the first quarter of 2025 with $39,513 in cash on hand.

The accompanying condensed consolidated financial statements have been prepared assuming that the Company will continue as a going concern, which contemplates the realization of assets and the liquidation of liabilities in the normal course of business. We incurred net losses of $107,364 and

$222,568, respectively, for the three months ended March 31, 2025 and 2024 and had an accumulated deficit of $83,920,681 as of March 31, 2025. The Company may seek to raise money for working capital purposes through a public offering of its equity capital or through a private placement of equity capital or convertible debt. It will be important for the Company to be successful in its efforts to raise capital in this manner if it is going to be able to further its business plan in an aggressive manner. Raising capital in this manner will cause dilution to current shareholders.

The amount of cash on hand the Company has does not provide sufficient liquidity to meet the immediate needs of our current operations.

Off Balance Sheet Arrangements

None

Item 3. Quantitative and Qualitative Disclosures About Market Risk.

Not required.

Item 4. Controls and Procedures.

Disclosure Controls and Procedures

Conclusions of Management Regarding Effectiveness of Disclosure Controls and Procedures

At the end of the period covered by this Quarterly Report on Form 10-Q, an evaluation was carried out under the supervision and with the participation of the Company’s management, including the Chief Executive Officer (“CEO”) and Chief Financial Officer (“CFO”), of the effectiveness of the design and operations of the Company’s disclosure controls and procedures (as defined in Rule 13a – 15(e) and Rule 15d – 15(e) under the Exchange Act). Based on that evaluation, the CEO and the CFO have concluded that as of the end of the period covered by this report, the Company’s disclosure controls and procedures were not effective as it was determined that there were material weaknesses affecting our disclosure controls and procedures.

Management of the Company believes that these material weaknesses are due to the small size of the company’s accounting staff. The small size of the Company’s accounting staff may prevent adequate controls in the future, such as segregation of duties, due to the cost/benefit of remediation. To mitigate the current limited resources and limited employees, we rely heavily on direct management oversight of transactions, along with the use of external legal and accounting professionals. As the Company grows, management expects to increase the number of employees, which will enable us to implement adequate segregation of duties within the internal control framework.

Changes in Internal Control over Financial Reporting

There was no change in our internal control over financial reporting during the quarter ended March 31, 2025, that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.

PART II – OTHER INFORMATION

Item 1. Legal Proceedings.

We are not a party to any material legal proceedings, and, to the best of our knowledge, no such legal proceedings have been threatened against us.

Item 1A. Risk Factors

Not required.

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds.

None

Item 3. Defaults Upon Senior Securities.

None.

Item 4. Mine Safety Disclosures.

Not applicable.

Item 5. Other Information.

None.

Item 6. Exhibits.

The following documents are included as exhibits to this report:

(a) Exhibits

Exhibit Number	SEC Reference Number	Title of Document	Notes

3.1	3	Articles of Incorporation	(1)
3.2	3	Bylaws	(1)
31.1	31	Section 302 Certification of Principal Executive Officer
31.2	31	Section 302 Certification of Principal Financial Officer
32.1	32	Section 1350 Certification of Principal Executive Officer
32.2	32	Section 1350 Certification of Principal Financial Officer
101.INS		XBRL Instance Document	(2)
101.SCH		XBRL Taxonomy Extension Schema	(2)
101.CAL		XBRL Taxonomy Extension Calculation Linkbase	(2)
101.DEF		XBRL Taxonomy Extension Definition Linkbase	(2)
101.LAB		XBRL Taxonomy Extension Label Linkbase	(2)
101.PRE		XBRL Taxonomy Extension Presentation Linkbase	(2)

(1) Incorporated by reference to Exhibits 3.01 and 3.02 of the Company’s Registration Statement on Form 10 filed January 28, 2009.

(2) XBRL information is furnished and not filed for purposes of Sections 11 and 12 of the Securities Act of 1933 and Section 18 of the Securities Exchange Act of 1934, and is not subject to liability under those sections, is not part of any registration statement or prospectus to which it relates and is not incorporated or deemed to be incorporated by reference into any registration statement, prospectus or other document.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

Dogecoin Cash, Inc.

Date: May ____ 2025

By:

/s/ David Tobias

David Tobias

Principal Executive Officer

Principal Financial Officer

DOGECOIN CASH, INC.

Contents

		*Page*

FINANCIAL STATEMENTS - UNAUDITED – for the three months ended March 31, 2025 and 2024:

Condensed consolidated balance sheets		FS-2

Condensed consolidated statements of operations		FS-3

Condensed consolidated statements of changes in stockholders’ equity		FS-4

Condensed consolidated statements of cash flows		FS-5

Notes to condensed consolidated financial statements		FS-6 through FS-16

FS-1

DOGECOIN CASH, INC.
Formerly (CANNABIS SATIVA, INC.)

CONDENSED CONSOLIDATED BALANCE SHEETS - UNAUDITED

	March 31,	December 31,
	2025	2024
ASSETS
Current Assets
Cash	`$39,513`	`$34,934`
Investment in equity securities, at fair value	`321,000`	`317,100`

Total Current Assets	`360,513`	`352,034`


Advances to related parties	`76,305`	`76,305`
Property and equipment, net	`2,094`	`2,163`
Intangible assets, net	`3,970`	`4,203`
Goodwill	`1,275,811`	`1,275,811`

Total Assets	`$1,718,693`	`$1,710,516`

LIABILITIES AND STOCKHOLDERS' DEFICIT

Current Liabilities
Accounts payable and accrued expenses	`$164,922`	`$149,480`
Accrued interest - related parties	`32,779`	`30,005`
Fair value of convertible component in convertible loans	`174,490`	`174,490`
Convertible notes payable	`177,736`	`177,736`
Notes payable to related parties	`196,988`	`184,038`

Total Current Liabilities	`746,915`	`715,749`

Long-term liabilities
Stock payable	`1,208,014`	`1,123,639`

Total Liabilities	`1,954,929`	`1,839,388`

Commitments and contingencies (Notes 6 and 8)

Stockholders' Deficit
Preferred Stock $0.001 par value; 5,000,000 shares authorized; 4,500,000 and -0- shares issued and outstanding, respectively	`4,500`	`4,500`
Common stock $0.001 par value; 495,000,000 shares authorized; 143,903,923 and 88,814,037 shares issued and outstanding, respectively	`143,904`	`143,904`
Additional paid-in capital	`82,229,325`	`82,229,325`
Accumulated deficit	`(83,920,681)`	`(83,816,573)`

Total Cannabis Sativa, Inc. Stockholders' Deficit	`(1,542,952)`	`(1,438,844)`

Non-Controlling Interest	`1,306,716`	`1,309,972`

Total Stockholders' Deficit	`(236,236)`	`(128,872)`

Total Liabilities and Stockholders' Deficit	`$1,718,693`	`$1,710,516`


The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.

FS-2

DOGECOIN CASH, INC.
Formerly (CANNABIS SATIVA, INC.)

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - UNAUDITED



For the three months ended March 31,	2025	2024

Revenues	`$184,473`	`$225,131`

Cost of Revenues	`67,506`	`99,018`

Gross Profit	`116,967`	`126,113`

Operating Expenses
Professional fees	`37,860`	`57,637`
Depreciation and amortization	`301`	`2,425`
Wages and salaries	`73,390`	`114,071`
Advertising	`1,861`	`1,880`
General and administrative	`105,169`	`124,891`

Total Operating Expenses	`218,581`	`300,904`

Loss from Operations	`(101,614)`	`(174,791)`

Other Income and (Expenses)
Unrealized gain (loss) on investment	`3,900`	`(14,850)`
Gain on debt settlement	`-`	`8,333`
Loss on return of investment securities	`-`	`(33,000)`
Interest expense	`(9,650)`	`(8,260)`

Total Other Income and (Expenses), Net	`(5,750)`	`(47,777)`

Loss Before Income Taxes	`(107,364)`	`(222,568)`

Income Taxes	`-`	`-`

Net Loss for the Period	`(107,364)`	`(222,568)`

Loss for the period attributable to non-controlling interest - PrestoCorp	`(3,256)`	`(22,295)`

Net Loss for the Period Attributable To Cannabis Sativa, Inc.	`$(104,108)`	`$(200,273)`


Net Loss for the Period per Common Share: Basic & Diluted	`$(0.00)`	`$(0.02)`

Weighted Average Common Shares Outstanding:
Basic & Diluted	`143,903,923`	`88,814,039`

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.

FS-3

DOGECOIN CASH, INC.

Formerly (CANNABIS SATIVA, INC.)

CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY (DEFICIT) FOR THE THREE MONTHS ENDED MARCH 31, 2025 AND 2024 - UNAUDITED

Preferred Stock

Common Stock

Additional

Paid-In

Accumulated

Non-controlling

Interest -

Shares

Amount

Shares

Amount

Capital

Deficit

Prestocorp

Total

Balance - January 1, 2024

-

$-

88,814,037

$88,815

$81,392,196

$(82,083,492)

$1,359,872

$757,391

Net loss for the period

-

(200,273)

(22,295)

(222,568)

Balance - March 31, 2024

-

$-

88,814,037

$88,815

$81,392,196

$(82,283,765)

$1,337,577

$534,823

Balance - January 1, 2025

4,500,000

$4,500

143,903,921

$143,904

$82,229,325

$(83,816,573)

$1,309,972

$(128,872)

Net loss for the period

-

(104,108)

(3,256)

(107,364)

Balance - March 31, 2025

4,500,000

$4,500

143,903,921

$143,904

$82,229,325

$(83,920,681)

$1,306,716

$(236,236)

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.

FS-4

DOGECOIN CASH, INC.
Formerly (CANNABIS SATIVA, INC.)

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - UNAUDITED


For the three months ended March 31,	2025	2024

Cash Flows From Operating Activities:
Net loss for the period	`$(107,364)`	`$(222,568)`
Adjustments to reconcile net loss for the period to net cash
used in operating activities:
Unrealized loss on investments	`(3,900)`	`14,850`
Depreciation and amortization	`301`	`2,425`
Loss on debt settlement	`-`	`(8,333)`
Loss on return of investment securities	`-`	`33,000`
Stock payable for services	`84,375`	`112,153`
Note payable issued for services	`12,500`	`15,000`
Changes in Assets and Liabilities:
Accounts payable and accrued expenses	`15,443`	`27,979`
Accrued interest - related parties	`2,774`	`750`
Net Cash Provided by (Used in) Operating Activities	`4,129`	`(24,744)`

Cash Flows from Investing Activities:
Net Cash Used in Investing Activities	`-`	`-`

Cash Flows from Financing Activities:
Proceeds from related parties notes payable, net	`450`	`-`
Net Cash Provided by Financing Activities	`450`	`-`

NET CHANGE IN CASH	`4,579`	`(24,744)`

CASH AT BEGINNING OF PERIOD	`34,934`	`83,762`

CASH AT END OF PERIOD	`$39,513`	`$59,018`



Supplemental Disclosures of Non Cash Activities:
Noncash investing and financing activities
Convertible note issued for payable	`$-`	`$86,022`

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.

	·	PrestoCorp, Inc. (“PrestoCorp”)
	·	DogeSPAC LLC
	·	Wild Earth Naturals, Inc. (“Wild Earth”)
	·	Kubby Patent and Licenses Limited Liability Company (“KPAL”)
	·	Hi Brands, International, Inc. (“Hi Brands”)
	·	Eden Holdings LLC (“Eden”).

	March 31,			December 31,
	2025			2024
CBDS.com website (Cannabis Sativa)	$	13,999		$	13,999
Intellectual Property Rights (PrestoCorp)		240,000			240,000
Patents and Trademarks (KPAL)		1,281,411			1,281,411
Total Intangibles		1,535,410			1,535,410
Less: Accumulated Amortization		(1,531,440	)		(1,531,207	)
Net Intangible Assets	$	3,970		$	4,203

April 1, 2025 to March 31, 2026	$	`932`
April 1, 2026 to March 31, 2027		`932`
April 1, 2027 to March 31, 2028		`932`
April 1, 2028 to March 31, 2029		`932`
April 1, 2029 to March 31, 2030		`242`

Account	Debit	Credit
Investment in DogeSPAC LLC	`$306,000`
Series A Preferred Stock (par)		`$4,500`
Additional Paid in Capital		`$301,500`